Compounds > 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine
Page last updated: 2024-09-03

2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and ofloxacin

2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine has been researched along with ofloxacin in 1 studies

Compound Research Comparison

Studies
(2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine)		Trials
(2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine)		Recent Studies (post-2010)
(2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine)		Studies
(ofloxacin)		Trials
(ofloxacin)		Recent Studies (post-2010) (ofloxacin)
1356506,4849761,346

Protein Interaction Comparison

ProteinTaxonomy2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (IC50)ofloxacin (IC50)
DNA gyrase subunit AEscherichia coli K-121.5
DNA gyrase subunit BEscherichia coli K-121.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagashima, R; Nishikawa, T; Tobita, M1

Other Studies

1 other study(ies) available for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and ofloxacin

ArticleYear
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
    Bioorganic & medicinal chemistry letters, 2005, Jun-02, Volume: 15, Issue:11

    Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated

2005